A nationwide survey published in the Journal of Intensive Medicine provides a detailed overview of intensive care units (ICU) across mainland China. The study analyzed responses from intensivists working in hospitals across 31 provinces. It examined ICU capacity, workforce characteristics, disease patterns, and medical technologies. While treatments such as mechanical ventilation are widely available, advanced technologies like extracorporeal membrane oxygenation remain limited. The findings highlight regional disparities and offer insights for strengthening critical care planning.

A new genome-based study has revealed how geographic dispersal reshaped the genetic diversity and key traits of Crotalaria pallida, a tropical legume valued for agriculture and medicine.

The Korea Research Institute of Standards and Science (KRISS, President Dr. Lee Ho Seong) has developed an ultra-sensitive immunoassay-based analytical platform that can detect and quantify trace amounts of “Small Excised Damaged DNA (sedDNA)” fragments generated during cellular DNA repair. This technology enables highly sensitive detection with quantification down to the level of several thousand molecules, measuring up to 22 times more DNA fragments than conventional methods. It provides a new analytical foundation for comparing DNA repair capacity between individuals and studying cellular responses to anticancer drugs and carcinogenic agents.

Bacterial pneumonia poses a major global public health threat. Among bacterial pneumonias, methicillin-resistant Staphylococcus aureus (MRSA) pneumonia presents particular clinical challenges due to multidrug resistance and complex pathological mechanisms. Addressing the challenging issue of the vicious cycle of infection inflammation injury in the treatment of MRSA pneumonia. Yan-Jun Hu et al. designed a glycosylated mesoporous polydopamine nanoaerosol (MPDA/B@M), which achieved effective treatment of MRSA infected pneumonia through multi mechanism synergistic effects.

Recently, a research team led by Professors Dahong Zhang and Qi Zhang from the Urology Department and the Institute of Urology at Zhejiang Provincial People's Hospital and the Translational Medicine Center discovered that a bladder tumor-targeting polyarginine peptide, R11, can directly bind to actin, destabilize the G-actin tetramer, and trigger the cascade breakdown of the actin–plectin–vimentin/ITGβ4 axis (referred to as the “cytoskeletal domino effect”).